GPCRStructure Therapeutics Inc.

$21.17-23% 1Y

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk99% volderived · Oct 23, 2026

Large price swings, high volatility. Worst drawdown -81% · now 77% below its 52-week high.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitybottom 5% of the market
Max drawdownbehind 76% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can GPCR take a bad year?

The deepest fall in GPCR's price history on file is −81%; it is 77% below its high today.

−81%

Worst drawdown on file · −77% today

Cash runway
5+ years

Cash runway · burning $56M a quarter at the current rate

Annualised volatility
99%

Annualised volatility · S&P 500 16% · about 6 times the market's own swing

Details›
Cash and short-term investments
$1.34B
EBITDA, trailing twelve months
−$256M
Operating profit, trailing twelve months
−$258M
Annualised volatilitytwo years of daily moves
99%
Worst drawdown on file
−81%
Below its 52-week high
77%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.

How far can it fall?

How much the price moves, how deep and how long its falls have run, and what each unit of risk has paid.

On our screens:Most shorted stocks